NCT00323687View on ClinicalTrials.gov

SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada

PHASE4CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2006

Study Completion Date

January 31, 2007

Conditions

HIV-1 Infection

Interventions

DRUG

Truvada

300mg / 200 mg QD tenofovir DF and Emtricitabine Fixed Dose Combination (FDC) Tablet (oral)

Trial Locations (1)

82152

Gilead Sciences GmbH, Martinsried

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY

NCT00323687 - SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada | Biotech Hunter | Biotech Hunter